Tryptase and Exogenous Trypsin: Mechanisms and Ophthalmic Applications

References

• Boyer JL, Basu AK. Sulfobromophthalein liver function test in patients with portal hypertension. Indian J Med Res. 1966;54(9):858–872. doi:10.1109/PROC.1966.4891
   Web of Science ®Google Scholar
• Kuo IC. Corneal wound healing. Curr Opin Ophthalmol. 2004;15(4):311–315. doi:10.1097/00055735-200408000-00006
   PubMedGoogle Scholar
• Zhang X, Qu MVJ, He X, et al. Dry eye management: targeting the ocular surface microenvironment. Int J Mol Sci. 2017;18(7):1398. doi:10.3390/ijms18071398
   PubMed Web of Science ®Google Scholar
• Baudouin C, Kolko M, Melik-Parsadaniantz S, Messmer EM. Inflammation in Glaucoma: from the back to the front of the eye, and beyond. Prog Retin Eye Res. 2021;83:100916. doi:10.1016/j.preteyeres.2020.100916
   PubMed Web of Science ®Google Scholar
• Skaper SD, Facci L, Zusso M, An Inflammation-Centric GP. View of Neurological Disease: beyond the Neuron. Front Cell Neurosci. 2018;12:72. doi:10.3389/fncel.2018.00072
   PubMed Web of Science ®Google Scholar
• Konnai M, Takahashi K, Machida Y, Michishita M, Ohkusu-Tsukada K. Intrahepatic eosinophilic proliferative phlebitis in Japanese black cattle indicate allergies involving mast cell tryptase-dependent activation. Front Vet Sci. 2022;9:972180. doi:10.3389/fvets.2022.972180
   Web of Science ®Google Scholar
• Meher S, Mishra TS, Sasmal PK, et al. Role of Biomarkers in Diagnosis and Prognostic Evaluation of Acute Pancreatitis. J Biomark. 2015;2015:519534. doi:10.1155/2015/519534
   PubMedGoogle Scholar
• Asano-Kato N, Fukagawa K, Okada N, Dogru M, Tsubota K, Fujishima H. Tryptase increases proliferative activity of human conjunctival fibroblasts through protease-activated receptor-2. Invest Ophthalmol Vis Sci. 2005;46(12):4622–4626. doi:10.1167/iovs.05-0388
   Web of Science ®Google Scholar
• Fan M, Wedamulla NE, Choi YJ, Zhang Q, Bae SM, Kim EK. Tenebrio molitor Larva Trypsin Hydrolysate Ameliorates Atopic Dermatitis in C57BL/6 Mice by Targeting the TLR-Mediated MyD88-Dependent MAPK Signaling Pathway. Nutrients. 2022;15:1. doi:10.3390/nu15010093
   Web of Science ®Google Scholar
• Ohlsson B, Yusa T, Rehfeld JF, Lundquist I, Ihse I, Axelson J. Effects of intraluminal trypsin and bile on the exocrine and endocrine pancreas after pancreaticobiliary diversion and biliodigestive shunt. Pancreas. 2000;20(2):170–176. doi:10.1097/00006676-200003000-00010
   Web of Science ®Google Scholar
• Cederqvist K, Janer J, Tervahartiala T, et al. Up-regulation of trypsin and mesenchymal MMP-8 during development of hyperoxic lung injury in the rat. Pediatr Res. 2006;60(4):395–400. doi:10.1203/01.pdr.0000238342.16081.f9
   Web of Science ®Google Scholar
• Zanotto GM, Liesbeny P, Barrett M, et al. Microfracture Augmentation With Trypsin Pretreatment and Growth Factor-Functionalized Self-assembling Peptide Hydrogel Scaffold in an Equine Model. Am J Sports Med. 2021;49(9):2498–2508. doi:10.1177/03635465211021798
   Web of Science ®Google Scholar
• Elieh Ali Komi D, Wöhrl S, Bielory L. Mast Cell Biology at Molecular Level: a Comprehensive Review. Clin Rev Allergy Immunol. 2020;58(3):342–365. doi:10.1007/s12016-019-08769-2
   PubMed Web of Science ®Google Scholar
• Rao KN, Brown MA. Mast cells: multifaceted immune cells with diverse roles in health and disease. Ann N Y Acad Sci. 2008;1143:83–104. doi:10.1196/annals.1443.023
   PubMed Web of Science ®Google Scholar
• Varricchi G, Rossi FW, Galdiero MR, et al. Physiological Roles of Mast Cells: collegium Internationale Allergologicum Update 2019. Int Arch Allergy Immunol. 2019;179(4):247–261. doi:10.1159/000500088
   PubMed Web of Science ®Google Scholar
• Kroner J, Kovtun A, Kemmler J, et al. Mast Cells Are Critical Regulators of Bone Fracture-Induced Inflammation and Osteoclast Formation and Activity. J Bone Miner Res. 2017;32(12):2431–2444. doi:10.1002/jbmr.3234
   PubMed Web of Science ®Google Scholar
• Lind T, Gustafson AM, Calounova G, et al. Increased Bone Mass in Female Mice Lacking Mast Cell Chymase. PLoS One. 2016;11(12):e0167964. doi:10.1371/journal.pone.0167964
   PubMed Web of Science ®Google Scholar
• Bagher M, Larsson-Callerfelt AK, Rosmark O, Hallgren O, Bjermer L, Westergren-Thorsson G. Mast cells and mast cell tryptase enhance migration of human lung fibroblasts through protease-activated receptor 2. Cell Commun Signal. 2018;16(1):59. doi:10.1186/s12964-018-0269-3
   Google Scholar
• Cairns JA, Walls AF. Mast cell tryptase stimulates the synthesis of type I collagen in human lung fibroblasts. J Clin Invest. 1997;99(6):1313–1321. doi:10.1172/jci119290
   Web of Science ®Google Scholar
• Varricchi G, Loffredo S, Galdiero MR, et al. Innate effector cells in angiogenesis and lymphangiogenesis. Curr Opin Immunol. 2018;53:152–160. doi:10.1016/j.coi.2018.05.002
   PubMed Web of Science ®Google Scholar
• Paduch R. The role of lymphangiogenesis and angiogenesis in tumor metastasis. Cell Oncol. 2016;39(5):397–410. doi:10.1007/s13402-016-0281-9
   PubMed Web of Science ®Google Scholar
• Adams RH, Alitalo K. Molecular regulation of angiogenesis and lymphangiogenesis. Nat Rev Mol Cell Biol. 2007;8(6):464–478. doi:10.1038/nrm2183
   PubMed Web of Science ®Google Scholar
• Mukai K, Tsai M, Saito H, Galli SJ. Mast cells as sources of cytokines, chemokines, and growth factors. Immunol Rev. 2018;282(1):121–150. doi:10.1111/imr.12634
   PubMed Web of Science ®Google Scholar
• de Souza Junior DA, Borges AC, Santana AC, Oliver C, Jamur MC. Mast Cell Proteases 6 and 7 Stimulate Angiogenesis by Inducing Endothelial Cells to Release Angiogenic Factors. PLoS One. 2015;10(12):e0144081. doi:10.1371/journal.pone.0144081
   Web of Science ®Google Scholar
• Bingham CO 3rd, Austen KF. Mast-cell responses in the development of asthma. J Allergy Clin Immunol. 2000;105(2 Pt 2):S527–534. doi:10.1016/s0091-6749(00)90056-3
   Web of Science ®Google Scholar
• Ricci-Vitiani L, Pallini R, Biffoni M, et al. Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells. Nature. 2010;468(7325):824–828. doi:10.1038/nature09557
   PubMed Web of Science ®Google Scholar
• Farnsworth RH, Lackmann M, Achen MG, Stacker SA. Vascular remodeling in cancer. Oncogene. 2014;33(27):3496–3505. doi:10.1038/onc.2013.304
   PubMed Web of Science ®Google Scholar
• Ribatti D, Crivellato E. Mast cells, angiogenesis and cancer. Adv Exp Med Biol. 2011;716:270–288. doi:10.1007/978-1-4419-9533-9_14
   PubMed Web of Science ®Google Scholar
• Tabbara KF. Tear tryptase in vernal keratoconjunctivitis. Arch Ophthalmol. 2001;119(3):338–342. doi:10.1001/archopht.119.3.338
   PubMedGoogle Scholar
• Pham CT. Neutrophil serine proteases fine-tune the inflammatory response. Int J Biochem Cell Biol. 2008;40(6–7):1317–1333. doi:10.1016/j.biocel.2007.11.008
   PubMed Web of Science ®Google Scholar
• Zhao P, Lieu T, Barlow N, et al. Neutrophil Elastase Activates Protease-activated Receptor-2 (PAR2) and Transient Receptor Potential Vanilloid 4 (TRPV4) to Cause Inflammation and Pain. J Biol Chem. 2015;290(22):13875–13887. doi:10.1074/jbc.M115.642736
   PubMed Web of Science ®Google Scholar
• Graves N, Venu VP, Yipp BG, et al. A Trypsin-Sensitive Proteoglycan from the Tapeworm Hymenolepis diminuta Inhibits Murine Neutrophil Chemotaxis in vitro by Suppressing p38 MAP Kinase Activation. J Innate Immun. 2019;11(2):136–149. doi:10.1159/000492303
   Web of Science ®Google Scholar
• Kolaczkowska E, Kubes P. Neutrophil recruitment and function in health and inflammation. Nat Rev Immunol. 2013;13(3):159–175. doi:10.1038/nri3399
   PubMed Web of Science ®Google Scholar
• Aragona P, Aguennouz M, Rania L, et al. Matrix metalloproteinase 9 and transglutaminase 2 expression at the ocular surface in patients with different forms of dry eye disease. Ophthalmology. 2015;122(1):62–71. doi:10.1016/j.ophtha.2014.07.048
   PubMed Web of Science ®Google Scholar
• Pflugfelder SC, Bian F, De Paiva C. Matrix metalloproteinase-9 in the pathophysiology and diagnosis of dry eye syndrome. Metalloproteinases Med. 2017;4:37–46.
   Google Scholar
• Li B, Sheng M, Li J, et al. Tear proteomic analysis of Sjögren syndrome patients with dry eye syndrome by two-dimensional-nano-liquid chromatography coupled with tandem mass spectrometry. Sci Rep. 2014;4:5772. doi:10.1038/srep05772
   PubMed Web of Science ®Google Scholar
• Wang H, He S. Induction of lactoferrin and IL-8 release from human neutrophils by tryptic enzymes via proteinase activated receptor-2. Cell Biol Int. 2006;30(9):688–697. doi:10.1016/j.cellbi.2006.04.007
   Web of Science ®Google Scholar
• Ramachandran R, Altier C, Oikonomopoulou K, Hollenberg MD. Proteinases, Their Extracellular Targets, and Inflammatory Signaling. Pharmacol Rev. 2016;68(4):1110–1142. doi:10.1124/pr.115.010991
   PubMed Web of Science ®Google Scholar
• Vergnolle N, Wallace JL, Bunnett NW, Hollenberg MD. Protease-activated receptors in inflammation, neuronal signaling and pain. Trends Pharmacol Sci. 2001;22(3):146–152. doi:10.1016/s0165-6147(00)01634-5
   PubMed Web of Science ®Google Scholar
• Lourbakos A, Potempa J, Travis J, et al. Arginine-specific protease from Porphyromonas gingivalis activates protease-activated receptors on human oral epithelial cells and induces interleukin-6 secretion. Infect Immun. 2001;69(8):5121–5130. doi:10.1128/iai.69.8.5121-5130.2001
   PubMed Web of Science ®Google Scholar
• Kawabata A, Kuroda R. Protease-activated receptor (PAR), a novel family of G protein-coupled seven trans-membrane domain receptors: activation mechanisms and physiological roles. Jpn J Pharmacol. 2000;82(3):171–174. doi:10.1254/jjp.82.171
   Google Scholar
• Kawabata A. Physiological functions of protease-activated receptor-2. Nihon Yakurigaku Zasshi. 2003;121(6):411–420. doi:10.1254/fpj.121.411
   Google Scholar
• Sitaras N, Rivera JC, Noueihed B, et al. Retinal neurons curb inflammation and enhance revascularization in ischemic retinopathies via proteinase-activated receptor-2. Am J Pathol. 2015;185(2):581–595. doi:10.1016/j.ajpath.2014.10.020
   Web of Science ®Google Scholar
• Joossen C, Baán A, Moreno-Cinos C, et al. A novel serine protease inhibitor as potential treatment for dry eye syndrome and ocular inflammation. Sci Rep. 2020;10(1):17268. doi:10.1038/s41598-020-74159-w
   Web of Science ®Google Scholar
• Li Q, Jie Y, Wang C, Zhang Y, Guo H, Pan Z. Tryptase compromises corneal epithelial barrier function. Cell Biochem Funct. 2014;32(2):183–187. doi:10.1002/cbf.2991
   Web of Science ®Google Scholar
• Safavi F, Rostami A. Role of serine proteases in inflammation: bowman-Birk protease inhibitor (BBI) as a potential therapy for autoimmune diseases. Exp Mol Pathol. 2012;93(3):428–433. doi:10.1016/j.yexmp.2012.09.014
   PubMed Web of Science ®Google Scholar
• Oyamada S, Bianchi C, Takai S, Chu LM, Sellke FW. Chymase inhibition reduces infarction and matrix metalloproteinase-9 activation and attenuates inflammation and fibrosis after acute myocardial ischemia/reperfusion. J Pharmacol Exp Ther. 2011;339(1):143–151. doi:10.1124/jpet.111.179697
   PubMed Web of Science ®Google Scholar
• Lee HM, Kim HY, Kang HJ, et al. Up-regulation of protease-activated receptor 2 in allergic rhinitis. Ann Otol Rhinol Laryngol. 2007;116(7):554–558. doi:10.1177/000348940711600712
   Web of Science ®Google Scholar
• Chalastras T, Nicolopoulou-Stamati P, Patsouris E, et al. Expression of substance P, vasoactive intestinal peptide and heat shock protein 70 in nasal mucosal smears of patients with allergic rhinitis: investigation using a liquid-based method. J Laryngol Otol. 2008;122(7):700–706. doi:10.1017/s0022215107001454
   Web of Science ®Google Scholar
• Bonini S, Schiavone M, Bonini S, et al. Efficacy of lodoxamide eye drops on mast cells and eosinophils after allergen challenge in allergic conjunctivitis. Ophthalmology. 1997;104(5):849–853. doi:10.1016/s0161-6420(97)30223-1
   PubMed Web of Science ®Google Scholar
• Micera A, Jirsova K, Esposito G, Balzamino BO, Di Zazzo A, Bonini S. Mast Cells Populate the Corneoscleral Limbus: new Insights for Our Understanding of Limbal Microenvironment. Invest Ophthalmol Vis Sci. 2020;61(3):43. doi:10.1167/iovs.61.3.43
   Web of Science ®Google Scholar
• Bhutto IA, McLeod DS, Jing T, Sunness JS, Seddon JM, Lutty GA. Increased choroidal mast cells and their degranulation in age-related macular degeneration. Br J Ophthalmol. 2016;100(5):720–726. doi:10.1136/bjophthalmol-2015-308290
   PubMed Web of Science ®Google Scholar
• McMenamin PG, Polla E. Mast cells are present in the choroid of the normal eye in most vertebrate classes. Vet Ophthalmol. 2013;16(Suppl 1):73–78. doi:10.1111/vop.12035
   Google Scholar
• Iddamalgoda A, Le QT, Ito K, Tanaka K, Kojima H, Kido H. Mast cell tryptase and photoaging: possible involvement in the degradation of extra cellular matrix and basement membrane proteins. Arch Dermatol Res. 2008;300(Suppl 1):S69–76. doi:10.1007/s00403-007-0806-1
   PubMed Web of Science ®Google Scholar
• McLeod DS, Bhutto I, Edwards MM, Gedam M, Baldeosingh R, Lutty GA. Mast Cell-Derived Tryptase in Geographic Atrophy. Invest Ophthalmol Vis Sci. 2017;58(13):5887–5896. doi:10.1167/iovs.17-22989
   PubMed Web of Science ®Google Scholar
• Curcio CA, Johnson M, Huang JD, Rudolf M. Apolipoprotein B-containing lipoproteins in retinal aging and age-related macular degeneration. J Lipid Res. 2010;51(3):451–467. doi:10.1194/jlr.R002238
   PubMed Web of Science ®Google Scholar
• Lee M, Sommerhoff CP, von Eckardstein A, Zettl F, Fritz H, Kovanen PT. Mast cell tryptase degrades HDL and blocks its function as an acceptor of cellular cholesterol. Arterioscler Thromb Vasc Biol. 2002;22(12):2086–2091. doi:10.1161/01.atv.0000041405.07367.b5
   Web of Science ®Google Scholar
• da Silva PS, Girol AP, Oliani SM. Mast cells modulate the inflammatory process in endotoxin-induced uveitis. Mol Vis. 2011;17:1310–1319.
   Web of Science ®Google Scholar
• May CA. Mast cell heterogeneity in the human uvea. Histochem Cell Biol. 1999;112(5):381–386. doi:10.1007/s004180050420
   Web of Science ®Google Scholar
• Fujita Y, Jin D, Mimura M, Sato Y, Takai S, Kida T. Activation of Mast-Cell-Derived Chymase in the Lacrimal Glands of Patients with IgG4-Related Ophthalmic Disease. Int J Mol Sci. 2022;23:5. doi:10.3390/ijms23052556
   Web of Science ®Google Scholar
• Ezzat M, Hann C, Vuk-Pavlovic S, Pulido J. Immune cells in the human choroid. Br j Ophthalmol. 2008;92(7):976–980.
   Web of Science ®Google Scholar
• Miller ST, Barney NP, Gamache DA, Spellman JM, Yanni JM. Secretory response of mast cells contained in monodispersed human choroidal preparations. Int Arch Allergy Immunol. 1997;114(2):139–143. doi:10.1159/000237659
   Web of Science ®Google Scholar
• Craig JP, Nichols KK, Akpek EK, et al. TFOS DEWS II Definition and Classification Report. Ocul Surf. 2017;15(3):276–283. doi:10.1016/j.jtos.2017.05.008
   PubMed Web of Science ®Google Scholar
• Ramos-Llorca A, Scarpellini C, Augustyns K. Proteases and Their Potential Role as Biomarkers and Drug Targets in Dry Eye Disease and Ocular Surface Dysfunction. Int J Mol Sci. 2022;23:17. doi:10.3390/ijms23179795
   Web of Science ®Google Scholar
• Macfarlane SR, Sloss CM, Cameron P, Kanke T, McKenzie RC, Plevin R. The role of intracellular Ca2+ in the regulation of proteinase-activated receptor-2 mediated nuclear factor kappa B signalling in keratinocytes. Br J Pharmacol. 2005;145(4):535–544. doi:10.1038/sj.bjp.0706204
   Web of Science ®Google Scholar
• Ribatti D, Ranieri G. Tryptase, a novel angiogenic factor stored in mast cell granules. Exp Cell Res. 2015;332(2):157–162. doi:10.1016/j.yexcr.2014.11.014
   PubMed Web of Science ®Google Scholar
• Chan CM, Huang JH, Chiang HS, et al. Effects of (-)-epigallocatechin gallate on RPE cell migration and adhesion. Mol Vis. 2010;16:586–595.
   Web of Science ®Google Scholar
• Louden C, Render JA, Carlton WW. Mast cell numbers in normal and glaucomatous canine eyes. Am J Vet Res. 1990;51(5):818–819.
   Web of Science ®Google Scholar
• Majji AB, Vemuganti GK, Shah VA, Singh S, Das T, Jalali S. A comparative study of epiretinal membranes associated with Eales’ disease: a clinicopathologic evaluation. Eye. 2006;20(1):46–54. doi:10.1038/sj.eye.6701788
   Web of Science ®Google Scholar
• Sato T, Morishita S, Horie T, et al. Involvement of premacular mast cells in the pathogenesis of macular diseases. PLoS One. 2019;14(2):e0211438. doi:10.1371/journal.pone.0211438
   Web of Science ®Google Scholar
• Ikeda T, Nakamura K, Oku H, et al. The role of tryptase and anti-type II collagen antibodies in the pathogenesis of idiopathic epiretinal membranes. Clin Ophthalmol. 2015;9:1181–1186. doi:10.2147/opth.S82015
   Google Scholar
• Morishita S, Sato T, Oosuka S, et al. Expression of Lymphatic Markers in the Berger’s Space and Bursa Premacularis. Int J Mol Sci. 2021;22:4. doi:10.3390/ijms22042086
   Web of Science ®Google Scholar
• Maruichi M, Oku H, Takai S, et al. Measurement of activities in two different angiotensin II generating systems, chymase and angiotensin-converting enzyme, in the vitreous fluid of vitreoretinal diseases: a possible involvement of chymase in the pathogenesis of macular hole patients. Curr Eye Res. 2004;29(4–5):321–325. doi:10.1080/02713680490516161
   PubMed Web of Science ®Google Scholar
• Ikeda T, Nakamura K, Morishita S, et al. Decreased Presence of Mast Cells in the Bursa Premacularis of Proliferative Diabetic Retinopathy. Ophthalmic Res. 2021;64(6):1002–1012. doi:10.1159/000518438
   Web of Science ®Google Scholar
• Ogura S, Baldeosingh R, Bhutto IA, et al. A role for mast cells in geographic atrophy. FASEB j. 2020;34(8):10117–10131. doi:10.1096/fj.202000807R
   PubMed Web of Science ®Google Scholar
• Palmer HS, Kelso EB, Lockhart JC, et al. Protease-activated receptor 2 mediates the proinflammatory effects of synovial mast cells. Arthritis Rheum. 2007;56(11):3532–3540. doi:10.1002/art.22936
   Google Scholar
• Weissler A, Mekori YA, Mor A. The role of mast cells in non-allergic inflammation. Isr Med Assoc J. 2008;10(12):843–845.
   Web of Science ®Google Scholar
• Russell FA, McDougall JJ. Proteinase activated receptor (PAR) involvement in mediating arthritis pain and inflammation. Inflamm Res. 2009;58(3):119–126. doi:10.1007/s00011-009-8087-0
   Web of Science ®Google Scholar
• Vergnolle N, Bunnett NW, Sharkey KA, et al. Proteinase-activated receptor-2 and hyperalgesia: a novel pain pathway. Nat Med. 2001;7(7):821–826. doi:10.1038/89945
   PubMed Web of Science ®Google Scholar
• Arizmendi NG, Abel M, Mihara K, et al. Mucosal allergic sensitization to cockroach allergens is dependent on proteinase activity and proteinase-activated receptor-2 activation. J Immunol. 2011;186(5):3164–3172. doi:10.4049/jimmunol.0903812
   Web of Science ®Google Scholar
• Ferrell WR, Lockhart JC, Kelso EB, et al. Essential role for proteinase-activated receptor-2 in arthritis. J Clin Invest. 2003;111(1):35–41. doi:10.1172/jci16913
   Web of Science ®Google Scholar
• Lohman RJ, Cotterell AJ, Barry GD, et al. An antagonist of human protease activated receptor-2 attenuates PAR2 signaling, macrophage activation, mast cell degranulation, and collagen-induced arthritis in rats. FASEB j. 2012;26(7):2877–2887. doi:10.1096/fj.11-201004
   PubMed Web of Science ®Google Scholar
• Suen JY, Barry GD, Lohman RJ, et al. Modulating human proteinase activated receptor 2 with a novel antagonist (GB88) and agonist (GB110). Br J Pharmacol. 2012;165(5):1413–1423. doi:10.1111/j.1476-5381.2011.01610.x
   PubMed Web of Science ®Google Scholar
• Sevigny LM, Zhang P, Bohm A, et al. Interdicting protease-activated receptor-2-driven inflammation with cell-penetrating pepducins. Proc Natl Acad Sci U S A. 2011;108(20):8491–8496. doi:10.1073/pnas.1017091108
   PubMed Web of Science ®Google Scholar
• Covic L, Gresser AL, Talavera J, Swift S, Kuliopulos A. Activation and inhibition of G protein-coupled receptors by cell-penetrating membrane-tethered peptides. Proc Natl Acad Sci U S A. 2002;99(2):643–648. doi:10.1073/pnas.022460899
   PubMed Web of Science ®Google Scholar
• Fala L. Zontivity (Vorapaxar), First-in-Class PAR-1 Antagonist, Receives FDA Approval for Risk Reduction of Heart Attack, Stroke, and Cardiovascular Death. Am Health Drug Benefits. 2015;8:148–151.
   PubMedGoogle Scholar
• Wang YJ, Yu SJ, Tsai JJ, Yu CH, Liao EC. Antagonism of Protease Activated Receptor-2 by GB88 Reduces Inflammation Triggered by Protease Allergen Tyr-p3. Front Immunol. 2021;12:557433. doi:10.3389/fimmu.2021.557433
   Web of Science ®Google Scholar
• Maruyama-Fumoto K, McGuire JJ, Fairlie DP, Shinozuka K, Kagota S. Activation of protease-activated receptor 2 is associated with blood pressure regulation and proteinuria reduction in metabolic syndrome. Clin Exp Pharmacol Physiol. 2021;48(2):211–220. doi:10.1111/1440-1681.13431
   Web of Science ®Google Scholar
• Congreve M, Oswald C, Marshall FH. Applying Structure-Based Drug Design Approaches to Allosteric Modulators of GPCRs. Trends Pharmacol Sci. 2017;38(9):837–847. doi:10.1016/j.tips.2017.05.010
   PubMed Web of Science ®Google Scholar
• Schoch C. In vitro inhibition of human conjunctival mast-cell degranulation by ketotifen. J Ocul Pharmacol Ther. 2003;19(1):75–81. doi:10.1089/108076803762718132
   PubMed Web of Science ®Google Scholar
• Grant SM, Goa KL, Fitton A. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in asthma and allergic disorders. Drugs. 1990;40(3):412–448. doi:10.2165/00003495-199040030-00006
   PubMed Web of Science ®Google Scholar
• Baba A, Tachi M, Ejima Y, et al. Anti-Allergic Drugs Tranilast and Ketotifen Dose-Dependently Exert Mast Cell-Stabilizing Properties. Cell Physiol Biochem. 2016;38(1):15–27. doi:10.1159/000438605
   PubMed Web of Science ®Google Scholar
• Varela-Fernández R, Díaz-Tomé V, Luaces-Rodríguez A, et al. Drug Delivery to the Posterior Segment of the Eye: biopharmaceutic and Pharmacokinetic Considerations. Pharmaceutics. 2020;12:3. doi:10.3390/pharmaceutics12030269
   Web of Science ®Google Scholar
• Schopf LR, Popov AM, Enlow EM, et al. Topical Ocular Drug Delivery to the Back of the Eye by Mucus-Penetrating Particles. Transl Vis Sci Technol. 2015;4(3):11. doi:10.1167/tvst.4.3.11
   PubMed Web of Science ®Google Scholar
• He SH. Key role of mast cells and their major secretory products in inflammatory bowel disease. World J Gastroenterol. 2004;10(3):309–318. doi:10.3748/wjg.v10.i3.309
   Web of Science ®Google Scholar
• Biziulevicius GA. Where do the immunostimulatory effects of oral proteolytic enzymes (‘systemic enzyme therapy’) come from? Microbial proteolysis as a possible starting point. Med Hypotheses. 2006;67(6):1386–1388. doi:10.1016/j.mehy.2006.05.051
   Web of Science ®Google Scholar
• Kerkhoffs GM, Struijs PA, de Wit C, Rahlfs VW, Zwipp H, van Dijk CN. A double blind, randomised, parallel group study on the efficacy and safety of treating acute lateral ankle sprain with oral hydrolytic enzymes. Br J Sports Med. 2004;38(4):431–435. doi:10.1136/bjsm.2002.004150
   Web of Science ®Google Scholar
• Taussig SJ, Batkin S. Bromelain, the enzyme complex of pineapple (Ananas comosus) and its clinical application. J Ethnopharmacol. 1988;22(2):191–203. doi:10.1016/0378-8741(88)90127-4
   Web of Science ®Google Scholar
• Nouza K, Wald M. Systemic enzyme therapy: problems of resorption of enzyme macromolecules. Cas Lek Cesk. 1995;134(19):615–619.
   Google Scholar
• Shah D, Mital K. The Role of Trypsin:Chymotrypsin in Tissue Repair. Adv Ther. 2018;35(1):31–42. doi:10.1007/s12325-017-0648-y
   Web of Science ®Google Scholar
• Bethune MT, Khosla C. Oral enzyme therapy for celiac sprue. Methods Enzymol. 2012;502:241–271. doi:10.1016/b978-0-12-416039-2.00013-6
   PubMed Web of Science ®Google Scholar
• Huijghebaert S, Vanham G, Van Winckel M, Allegaert K. Does Trypsin Oral Spray (Viruprotect(®)/ColdZyme(®)) Protect against COVID-19 and Common Colds or Induce Mutation? Caveats in Medical Device Regulations in the European Union. Int J Environ Res Public Health. 2021;18:10. doi:10.3390/ijerph18105066
   Web of Science ®Google Scholar
• Henrotin YE, Michlmayr C, Rau SM, Quirke AM, Bigoni M, Ueberall MA. Combination of Enzymes and Rutin to Manage Osteoarthritis Symptoms: lessons from a Narrative Review of the Literature. Rheumatol Ther. 2022;9(5):1305–1327. doi:10.1007/s40744-022-00472-7
   Web of Science ®Google Scholar
• Yu RL, Chen SW, Li LQ, Lin YG, Zhang FQ. Drug treatment and prognosis of community-acquired pneumonia in the elderly. Medical Frontier. 2019;9(27):2.
   Google Scholar
• Latha BR, Jayaraman M. The efficacy of trypsin: chymotrypsin preparation in the reduction of oxidative damage during burn injury. Burns. 1998;24(6):532–538. doi:10.1016/s0305-4179(98)00066-7
   PubMed Web of Science ®Google Scholar
• Iohara K, Zayed M, Takei Y, Watanabe H, Nakashima M. Treatment of Pulpectomized Teeth With Trypsin Prior to Transplantation of Mobilized Dental Pulp Stem Cells Enhances Pulp Regeneration in Aged Dogs. Front Bioeng Biotechnol. 2020;8:983. doi:10.3389/fbioe.2020.00983
   Web of Science ®Google Scholar
• Latha B, Ramakrishnan KM, Jayaraman V, Babu M. Action of trypsin: chymotrypsin(Chymoral forte DS) preparation on acute-phase proteins following burn injury in humans. Burns. 1997;23(Suppl 1):S3–7. doi:10.1016/s0305-4179(97)
   Google Scholar
• Brakenbury PH, Kotowski J. A comparative study of the management of ankle sprains. Br J Clin Pract. 1983;37(5):181–185.
   Google Scholar
• Mao YL, Xu HF. Treatment and difficulty of wound. Chine J Practical Surg. 2011;31(1):3.
   Google Scholar
• Chandanwale A, Langade D, Sonawane D, Gavai P, Randomized A. Clinical Trial to Evaluate Efficacy and Tolerability of Trypsin: chymotrypsinas Compared to Serratiopeptidase and Trypsin: bromelain:Rutosidein Wound Management. Adv Ther. 2017;34(1):180–198. doi:10.1007/s12325-016-0444-0
   Google Scholar
• Sadeghalvad M, Mohammadi-Motlagh HR, Karaji AG, Mostafaie A. In vivo anti-inflammatory efficacy of the combined Bowman-Birk trypsin inhibitor and genistein isoflavone, two biological compounds from soybean. J Biochem Mol Toxicol. 2019;33(12):e22406. doi:10.1002/jbt.22406
   PubMed Web of Science ®Google Scholar
• Latha B, Ramakrishnan M, Jayaraman V, Babu M. Serum enzymatic changes modulated using trypsin: chymotrypsin preparation during burn wounds in humans. Burns. 1997;23(7–8):560–564. doi:10.1016/s0305-4179(97)90093-0
   Web of Science ®Google Scholar
• Hamilton JA. Colony-stimulating factors in inflammation and autoimmunity. Nat Rev Immunol. 2008;8(7):533–544. doi:10.1038/nri2356
   PubMed Web of Science ®Google Scholar
• Abe R, Donnelly SC, Peng T, Bucala R, Metz CN. Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J Immunol. 2001;166(12):7556–7562. doi:10.4049/jimmunol.166.12.7556
   PubMed Web of Science ®Google Scholar
• Moeller A, Gilpin SE, Ask K, et al. Circulating fibrocytes are an indicator of poor prognosis in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2009;179(7):588–594. doi:10.1164/rccm.200810-1534OC
   PubMed Web of Science ®Google Scholar
• Reilkoff RA, Bucala R, Herzog EL. Fibrocytes: emerging effector cells in chronic inflammation. Nat Rev Immunol. 2011;11(6):427–435. doi:10.1038/nri2990
   PubMed Web of Science ®Google Scholar
• Naik-Mathuria B, Pilling D, Crawford JR, et al. Serum amyloid P inhibits dermal wound healing. Wound Repair Regen. 2008;16(2):266–273. doi:10.1111/j.1524-475X.2008.00366.x
   Web of Science ®Google Scholar
• White MJ, Glenn M, Gomer RH. Trypsin potentiates human fibrocyte differentiation. PLoS One. 2013;8(8):e70795. doi:10.1371/journal.pone.0070795
   Web of Science ®Google Scholar
• Iizaka S, Sanada H, Matsui Y, et al. Serum albumin level is a limited nutritional marker for predicting wound healing in patients with pressure ulcer: two multicenter prospective cohort studies. Clin Nutr. 2011;30(6):738–745. doi:10.1016/j.clnu.2011.07.003
   Web of Science ®Google Scholar
• Anthony D, Rafter L, Reynolds T, Aljezawi M. An evaluation of serum albumin and the sub-scores of the Waterlow score in pressure ulcer risk assessment. J Tissue Viability. 2011;20(3):89–99. doi:10.1016/j.jtv.2011.04.001
   Web of Science ®Google Scholar
• Gershenfeld HK, Hershberger RJ, Shows TB, Weissman IL. Cloning and chromosomal assignment of a human cDNA encoding a T cell- and natural killer cell-specific trypsin-like serine protease. Proc Natl Acad Sci U S A. 1988;85(4):1184–1188. doi:10.1073/pnas.85.4.1184
   Web of Science ®Google Scholar
• Nhu QM, Shirey KA, Pennini ME, Stiltz J, Vogel SN. Proteinase-activated receptor 2 activation promotes an anti-inflammatory and alternatively activated phenotype in LPS-stimulated murine macrophages. Innate Immun. 2012;18(2):193–203. doi:10.1177/1753425910395044
   PubMed Web of Science ®Google Scholar
• Bruni M, Quarti Trevano GM, Baresi A, Bellinzoni G. A follow-up of the protein pattern after operations in patients treated with an oral enzyme. Arzneimittelforschung. 1980;30(11):1922–1925.
   Web of Science ®Google Scholar
• Chen XQ, Jin YY, Tang G. New Pharmacology by Chen Xinqian. 18th ed. Hubei: Chen XQ; 2018.
   Google Scholar
• Pang B, Zhao Y. Clinical treatment and symptom outcome of conjunctivitis. World Clin Med. 2019;13(4):7–9.
   Google Scholar
• Hu LQ, Ni LL, Zhao MY. Clinical analysis of modified retrograde lacrimal duct catheterization plus chymotrypsin irrigation in the treatment of lacrimal duct obstruction. Chine Med Sci J. 2012;2(18):214–215.
   Google Scholar